Lisanti Capital Growth, LLC Veracyte, Inc. Transaction History

Lisanti Capital Growth, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	BUY	$15.31 - $29.94 $1.72 Million - $3.36 Million	112,365 New	112,365 $2.67 Million
Q2 2021 Aug 16, 2021	SELL	$32.94 - $56.62 $2.64 Million - $4.55 Million	-80,280 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$44.47 - $81.38 $347,755 - $636,391	-7,820 Reduced 8.88%	80,280 $4.32 Million
Q4 2020 Feb 10, 2021	BUY	$32.49 - $61.88 $2.86 Million - $5.45 Million	88,100 New	88,100 $4.31 Million
Q1 2020 May 11, 2020	SELL	$16.13 - $30.17 $1.71 Million - $3.21 Million	-106,272 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$20.78 - $29.99 $2.21 Million - $3.19 Million	106,272 New	106,272 $2.97 Million
Q3 2019 Nov 06, 2019	SELL	$23.87 - $30.93 $3.1 Million - $4.02 Million	-129,990 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$22.1 - $28.56 $607,308 - $784,828	27,480 Added 26.81%	129,990 $3.71 Million
Q1 2019 May 13, 2019	BUY	$12.0 - $25.76 $1.23 Million - $2.64 Million	102,510 New	102,510 $2.57 Million

307

81.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

Stay updated on Lisanti Capital Growth, LLC with notifications on news.